Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.113.125336
Full Text
Open PDFAbstract
Available in full text
Date
January 16, 2014
Authors
Publisher
Society of Nuclear Medicine